FLACS and Fuchs' Dystrophy | ASCRS
FLACS and Fuchs' Dystrophy
May 2019
Meeting: 2019 Annual Meeting
Authors: Germán Bianchi, MD; Josefina Botta, MD; Adriana Tytiun
Poster ID: 55670
You must be logged in to view this content

This resource is only available for ASCRS Members. Please log in using the teal "Login" button in the top right-hand corner to log in.

Poster Abstract

To evaluate corneal safety in patients with Fuchs' dystrophy after Femtosecond laser-assisted cataract surgery (FLACS)
A retrospective cohort study was performed to review clinical charts from patients with Fuchs' dystrophy operated by FLACS, between March 2016-March 2018. Mean endothelial cell density (CD) and central corneal thickness (CCT) were evaluated before and six months after surgery. Intra-postoperative complications were also evaluated.
A total of 30 eyes were evaluated. Preoperative CD: 2183.9 cell/mm2 (SD: 490.44; ±833-3002); six months after: 1871.9 cell/mm2 (SD: 548.1; ±606-2901). Decrease was 14.2%; “t” test p: 0.02 (p< 0.05; statistical significant difference). Preoperative CCT: 531.6 µm (SD: 49.2; ±434-627) and six months after: 534.6 µm (SD: 60.9; ±440-715); “t” test p: 0.83 (p>0.05: non-statistical significant difference). Postoperative mean CCT increase was 0.5% (3 µm).
FLACS performed in Fuchs' dystrophy patients seems to be a good surgical choice, regarding their corneal safety.

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.